Unlearn

About Unlearn

Unlearn is a healthcare AI platform focused on transforming clinical research through the use of digital twins. By creating personalized, predictive models of individual patients, the platform aims to make clinical trials more efficient and informative. These digital twins serve as simulated controls or baselines, potentially reducing the need for large placebo groups and enabling smaller, faster studies. The technology applies machine learning to historical and real-world data to forecast health trajectories, helping researchers make better-informed decisions at various stages of drug development.

Designed for sponsors, contract research organizations, and academic investigators, Unlearn integrates into existing trial workflows to enhance statistical power and reduce uncertainty. Its approach supports data-driven decision-making in protocol design, patient selection, and outcome analysis. By leveraging predictive analytics and simulation, the tool seeks to lower costs and timelines while maintaining rigorous scientific standards. Unlearn is positioned at the intersection of digital twin technology and clinical research, offering a novel way to accelerate the development of new therapies. The platform is applicable across therapeutic areas and trial phases where digital baseline predictions can strengthen study designs.